+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targazyme Inc - logo

Targazyme is a clinical-stage biopharmaceutical company developing and commercializing breakthrough products to improve clinical efficacy outcomes for immunotherapies for cancer and autoimmune diseases, stem cell transplants, gene therapy and regenerative medicine. Targazyme's products are off-the-shelf enzyme/substrate kits that are used to treat cells at the point-of-care, immediately before they are infused in the patient. The company was founded in 2005 and is based in Floresville, Texas with additional offices in San Diego, California; and Basel, Switzerland.

CAR T - Cell Therapy - Pipeline Insight, 2021 - Product Thumbnail Image

CAR T - Cell Therapy - Pipeline Insight, 2021

  • Drug Pipelines
  • May 2021
  • 60 pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 797 pages
From
From
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 770 pages
From
From
From
From
From
CAR-T - Pipeline Insight, 2021 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2021

  • Drug Pipelines
  • March 2021
  • 360 pages
From
From
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2289 pages
From
Erectile Dysfunction - Pipeline Review, H2 2020 - Product Thumbnail Image

Erectile Dysfunction - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 156 pages
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator
adroll